Evidence map›Paper›PMID 34814396›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].

Y Sun, H H Zhang, J S Zheng, Y H Zhang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Y SunMinimally Invasive Interventional Center of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
H H ZhangMinimally Invasive Interventional Center of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
J S ZhengMinimally Invasive Interventional Center of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Y H ZhangMinimally Invasive Interventional Center of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Beijing YouAn Hospital · CN

Funding

the Beijing Key Laboratory of Biomarkers for Infectious Diseases BZ0373the Natural Science Foundation of Beijing Municipality 7191004
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularCatheter AblationLiver NeoplasmsRadiofrequency AblationHepatic ArteryHumansNeoplasm Recurrence, LocalRetrospective StudiesRisk FactorsHepatocellular carcinomaRadiofrequency ablationRecurrenceTranscatheter arterial embolization

Identifiers

PMID34814396
PMCPMC12814256
OpenAlexW3215812790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.